mother post pregnancy

Postpartum Urinary Incontinence Linked to Mental Health

A UT Southwestern Medical Center study of hundreds of underserved women showed that depression and anxiety, in addition to physical factors such as a higher body mass index and previous births, are associated with lingering postpartum urinary incontinence. The findings, published in Urogynecology, shine a spotlight on these conditions that can carry stigmas but are largely treatable, researchers say. “Our study draws a bridge between two vital components of health care that are often overlooked and neglected: postpartum care and mental health,” said Sonia Bhandari Randhawa, M.D., a second-year Urogynecology fellow at UT Southwestern. Dr. Bhandari Randhawa co-led the study with David Rahn, M.D., Professor of Obstetrics and Gynecology at UTSW. Read more.

Source: UT Southwestern Medical Center, June 27, 2024

women friends

FDA Clears Yōni.Fit Device for Women With Stress Urinary Incontinence

The Food and Drug Administration (FDA) has cleared Yōni.Fit® Bladder Support for the temporary management of urine leakage caused by stress urinary incontinence (SUI) in women 18 years of age and older. Yōni.Fit is a self-administered, intravaginal insert that manages urinary incontinence without interfering with voluntary urination. The prescription device can be used during a specific activity or for up to 12 hours to control symptoms. Read more.

Source: Renal & Urology News, May 22, 2024

GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology

Graminex®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The study was conducted as a randomized, double-blind, placebo-controlled study to investigate the effectiveness of Graminex® Flower Pollen Extracts in 114 healthy women with urinary incontinence.  Read more.

Source: Business Wire, May 13, 2024

Understanding the Link Between Urinary Incontinence in Women and Disability Risk: Insights from Recent Medical Research

Urinary incontinence, a condition that affects millions of women worldwide, may have more severe implications than previously thought. A recent study from the Rush University Medical Center has added a new dimension to our understanding of this common health issue. According to the study, urinary incontinence in women is linked with a higher risk of disability. This finding is significant and has implications for both the management and treatment of urinary incontinence in women. Read more.

Source: Medriva, January 12, 2024

Female Incontinence: A Public Health Crisis?

Women’s health has a long history of being sidelined—that’s no great secret. Women’s health issues cloaked in embarrassment are uniquely at risk of being overlooked or ignored. Urinary (UI) and fecal incontinence (FI) are among them. Shame often keeps women from speaking about bothersome symptoms, which contributes to today’s grim reality: the adult diaper market now exceeds the market for baby diapers. With 62% of adult women living with bladder leaks, I feel female incontinence has reached the level of a public health crisis. Read more.

Source: MedCity News, December 6, 2023

women india

Axena Health Begins First-of-Its-Kind Global Study of Female Incontinence

Axena Health, Inc. (Axena Health), a women’s health medical device company focused on scalable treatments for female pelvic health, announced today a large-scale study that will investigate the burdens of incontinence on women in low- and middle-income countries to support equitable access to treatment. The first-of-its-kind study will examine how women could access treatment within local healthcare delivery systems and in a manner that accommodates cultural norms. Study results will be available in late 2023 and will inform the development of new treatment options based on the Leva® Pelvic Health System, a digital health treatment for urinary incontinence (UI) with published studies supporting its effectiveness, including durable, long-term symptom relief. Read more.

Source: Yahoo! Finance, May 19, 2023

exercise young woman

Incontinence Due to Pelvic Floor Issues Affects Women With DM1

Pelvic floor disorders, including urinary and anal incontinence, are common in women with myotonic dystrophy type 1 (DM1) and a cause of significant distress, according to a recent study in Canada.  “This study highlights the importance of screening these symptoms in a clinical setting and will help develop interventions to adequately treat these symptoms, taking into account the characteristics of the disease,” its researchers wrote. Ways of addressing urinary incontinence — reported by 60% of the women in this study — “should be explored due to the high prevalence of this disorder,” the team added. The study, “Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1,” was published in the journal Neuromuscular Disorders.  Read more.

Source: Bionews, January 17, 2023

cola drink beverage

Does What You Drink Affect Your Risk of Urinary Incontinence?

Urinary incontinence affects nearly 20% of women aged older than 50 years. Many factors can influence a woman’s risk of urinary incontinence. A new study suggests that despite some commonly held misconceptions, the consumption of artificially sweetened beverages does not have a significant effect on a woman’s likelihood of developing the condition. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). Read more.

Source: Newswise, December 14, 2022

Viveca Biomed Launches Contrelle To Create ‘Revolution’ In Tackling Stress Urinary Incontinence

Viveca Biomed has launched an innovative and clinically-proven bladder support device, Contrelle that offers women immediate relief from stress urinary incontinence (SUI) and provides community pharmacy contractors with a way to build a new consumer base, customer loyalty and sales margins. The product, named ‘Contrelle Activgard’, has already recorded millions of sales in Scandinavia over a decade. Read more.

Source: Pharmacy Business, August 24, 2022

nurse and patient

Prasterone Shows Promise In Reducing Severity of Urinary Urge Incontinence

Because of a decrease in estrogen, menopause is often accompanied by multiple vaginal and urinary issues. To date, most treatment options focus on vulvar and vaginal atrophy, with fewer options available to treat urinary incontinence. A new study, however, suggests prasterone is effective in improving the severity of urinary urge incontinence. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). Read more.

Source: Newswise, July 27, 2022